Profile for European Patent Office Patent: 1305329
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Luxembourg | 91429 | ⤷ Start Trial |
| Denmark | CA 2008 00022 | ⤷ Start Trial |
| Netherlands | 300343 | ⤷ Start Trial |
| Ireland | SPC011/2008 | ⤷ Start Trial |
| France | 08C0014 | ⤷ Start Trial |
| Switzerland | C01305329/01 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1305329
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
